Zhang, P., Sun, T., Wang, Y., Li, W., Tong, Z., Phadke, S., Feinstein, T., Ma, W., Guo, P., Zhang, M., Yue, Y., Xu, B. (2026). Afuresertib plus fulvestrant for pretreated HR-positive, HER2-negative, advanced breast cancer: a phase Ib trial. Nature Communications. https://doi.org/10.1038/s41467-026-69225-2